CANMAT Bipolar Disorder Guidelines Update Dr. Lakshmi Yatham (15:05 Minutes)
Metabolic Considerations in Mood Disorders Dr. Roger McIntyre (8:45 Minutes)
Understanding the Diagnostic and Treatment Implications of DSM-5 Mood Disorders with Mixed Features Dr. Joseph F. Goldberg (14:56 Minutes)
Post-test (optional)
Queen’s University developed this Self-Study Activity with STA Communications. The program was independently developed by a scientific planning committee, who reviewed the needs assessment data, current relevant literature and guidelines, provided their expert opinion, and devised the learning objectives. The planning committee members have approved the final content and confirm that the content is not biased, and is evidence-based. Any potential conflicts of interest have been disclosed, and all off-label discussions are declared.
Joseph F. Goldberg, MD Clinical Professor of Psychiatry, Icahn School of Medicine Mount Sinai Hospital New York, New York
Dianne L. Groll, PhD Associate Professor of Psychiatry and Psychology, Director of Research, Department of Psychiatry, Queen’s University, Kingston, Ontario
Roger McIntyre, MD, FRCPC Professor of Psychiatry and Pharmacology, University of Toronto Head of the Mood Disorders Psychopharmacology Unit, University Health Network Toronto, Ontario
Lakshmi Yatham, MBBS, FRCPC, MRCPsych(UK) Professor, Department of Psychiatry, Faculty of Medicine, University of British Columbia Regional Head of Psychiatry and Regional Program Medical Director, Vancouver Coastal Health & Providence Healthcare Vancouver, British Columbia
Treating the Mind, Respecting the Body: Clinical Considerations and Patient Centricity in the Management of Bipolar Disorder
Pre-test:
Participation in this pre-test is optional
Treating the Mind, Respecting the Body: Clinical Considerations and Patients Centricity in the Management of Bipolar Disoder
Post-test:
Thank you for completing this program’s pre-test.
Treating the Mind, Respecting the Body: Clinical Considerations and Patient Centricity in the Management of Bipolar Disorder
Post-test:
Participation in this post-test is optional
Treating the Mind, Respecting the Body: Clinical Considerations and Patients Centricity in the Management of Bipolar Disoder
Post-test:
Thank you for completing this program’s post-test.
Post-Test results
1) Question 1 (Dr. Yatham) What are new first-line pharmacological treatments for acute bipolar 1 depression per the 2018 CANMAT guidelines update? Pick the best answer.
a) Ketamine; adjunctive EPA; olanzapine + SSRI; quetiapine
b) Lurasidone; Lithium or divalproex + lamotrigine c) Lamotrigine as adjunctive therapy; lurasidone; lurasidone plus lithium + divalproex
d) Carbamezapine; olanzapine; divalproex
2) Question 2 (Dr. McIntyre) Given that obesity and diabetes can lead to alterations in the brain that can result in cognitive impairment, which of the following would be true regarding the selection of treatment options in mood disorders? Pick the best answer.
a) It is recommended to disregard adverse effects that affect metabolism and weight gain. b) It is recommended to avoid treatment options that adversely affect glucose or insulin homeostasis, or weight gain, where possible.
c) All available treatment options are equivalent in terms of their effect on glucose or insulin homeostasis, or weight gain.
d) None of the above.
3) Question 3 (Dr. McIntyre) What is an implication of well-controlled diabetes in the context of prevention of bipolar disorder and depression? Pick the best answer.
a) It would likely have no effect on preventing the onset of bipolar disorder.
b) We are not sure; more research is required.
c) It would definitely prevent the onset of bipolar disorder and depression. d) It could prevent the onset of bipolar disorder and depression.
4) Question 4 (Dr. Goldberg) Which statement accurately describes a mixed features episode in the DSM-V? Pick the best answer.
a) ≥ 5 symptoms of opposite polarity that do not overlap with the syndromal pole and can occur in bipolar 1 but not bipolar II. b) ≥ 3 symptoms of opposite polarity that do not overlap with the syndromal pole and can occur in bipolar 1 and bipolar II and unipolar major depressive disorder.
c) ≥ 3 symptoms of opposite polarity that do not overlap with the syndromal pole and occurs only in major depressive disorder.
d) ≥ 5 symptoms of opposite polarity that do not overlap with the syndromal pole and can occur in bipolar 1 and bipolar II.
5) Question 5 (Dr. Goldberg) What are some factors that discourage antidepressant use in bipolar disorder? Pick the best answer. (Note: rapid cycling refers to 4 or more episodes in the past 12 months).
a) bipolar I, mixed features, and past year of rapid cycling
b) bipolar II and absence of rapid cycling
c) bipolar I and mixed features
d) pure depressed episodes and prior favorable antidepressant use
The information and opinions contained herein reflect the views and experience of the authors and not necessarily those of the sponsors or STA Communications Inc. It is recommended that physicians evaluate their patient’s individual conditions before making a diagnosis or treatment decision. Any products mentioned herein should be used in accordance with the prescribing information contained in their respective product monographs. The content on this site is intended for health professionals.
